A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving ...

Columnist Jolie Lizana is not just happy to take a day of rest for National Relaxation Day; she contends that such rest is ...

Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...

Immune cell metabolism changes may underlie PAH inflammation, which could inform targets for new PAH treatment strategies.

After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...

People with portopulmonary hypertension (PoPH) show lower survival rates than other PAH types, but targeted PAH treatments ...

To reduce fatigue, the first thing columnist Jen Cueva did was analyze her sleep patterns, revealing some surprising results.

Exercise intolerance in PAH patients with treatment-related improvements in blood pressure was associated with impaired muscle function.